In this article, Appleyard Lees', Senior Associate and Patent Attorney, Sarah Gibbs, explores how the launch of two recently developed malaria vaccines, RTS,S and R21, marks a critical milestone in combating malaria. Sarah explores how integrating these vaccines with existing control measures in Africa sets out a promising path towards near-eradication of malaria.
Read more
The first revocation decision from the Unified Patent Court (UPC) has seen a win for Sanofi and Regeneron in a dispute with Amgen over cholesterol lowering drugs.
Read more
In this episode, Amritjot Jethwa, Head of Commercial IP Contracts, is joined by Chris Hoole, Partner, in providing a quick-fire summary of 5 important factors to consider as a Licensor and as a Licensee when licensing technology, creating the building blocks for the successful commercialisation of IP.
Read more
Written by trainees for trainees.
Appleyard Lees’ trainee patent attorney, Holly Redman, shares her experiences and learnings from presenting on equality, diversity, and inclusion, as a keynote speaker at an event titled: ‘Help! How do I start a conversation about ED&I?’, organised by IP Inclusive.
In this article, we explore and discuss emerging technological innovations designed to enhance care for individuals affected by Alzheimer's disease and dementia. Appleyard Lees supports organisations that create or enable innovation that makes life better and is proud to be supporting the UK's leading dementia charity, Alzheimer’s Society. Alzheimer’s Society are an organisation striving to eliminate the devastating impact of dementia worldwide, as our charity of the year.
Read more
Written by trainees for trainees.
Many intellectual property articles relating to European patent law cover specific “cases” and “decisions” from the European Patent Office (EPO) such as “T 1473/19”. Some instead cover broader trends in areas of “caselaw” such as “Patentability of second medical use claims at the EPO”. This article aims to provide a helpful understanding of the wider system from which these new interpretations of law emerge.
The UK Supreme Court has provided guidance on the circumstances upon which directors may be personally liable as an accessory to a tort (trade mark infringement is a tortious act) committed by their company.
Read more
Written by trainees for trainees.
On 18th April 2024 CIPA (the Chartered Institute of Patent Attorneys) hosted its annual Student Conference at the Crowne Plaza hotel in Birmingham. The event (aimed at trainee patent attorneys in the early stages of their career) involves a series of talks and is renowned for giving trainees across the UK the opportunity to connect and network with one another. The patent profession in the UK is fairly small, so there is a good chance the trainees at the student conference will continue to interact with each other throughout their careers.
Romania deposited its instrument of ratification of the Unified Patent Court Agreement on 31 May 2024, becoming the 18th member state to ratify the Agreement.
Read more
Sarah Gibbs discusses a recent decision from the European Patent Office on how intermediate generalisations should be assessed for added matter.
Read more
Getting a patent granted for your innovation can be a costly process. There are, of course, fees associated with the work your patent attorneys do to advise you, to prepare your patent application, and to work with the Patent Office to obtain a granted patent for you.
Read more
